Local and systemic delivery of an aspirin-triggered lipoxin stable analog inhibits neutrophil trafficking

Annals of the New York Academy of Sciences

Volumn 905, Issue , 2000, Pages 274-278

  Clish, Clary B ^a   Gronert, Karsten ^a   Serhan, Charles N ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; LIPOXIN;

ANIMAL EXPERIMENT; CONFERENCE PAPER; DRUG DELIVERY SYSTEM; INFLAMMATION; MOUSE; NEUTROPHIL; NONHUMAN;

ANIMALIA;

EID: 0034018421     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb06559.x     Document Type: Conference Paper

References (7)

1. 1. RIDKER, P.M., et al. 1997. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N. Engl. J. Med. 336: 973-979.
2. 2. HERSCHMAN, H.R. 1998. Recent progress in the cellular and molecular biology of prostaglandin synthesis. Trends Cardiovase. Med. 8: 145-150.
3. 4 ELISA. J. Pharmacol. Exp. Ther. 287: 779-790.
4. 4 analogs. J. Clin. Invest. 101: 1860-1869.
5. 5. CLISH, C.B., et al. 1999. Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo. Proc. Natl. Acad. Sci. U.S.A. 96: 8247-8252.
6. 6. ENSOR, C.M. & H.H. TAI. 1991. In Prostaglandins, Leukotrienes, Lipoxins, and PAF, J.M. Bailey, Ed.: 39-52. Plenum. New York.
7. 7. EDWARDS, J.C.W., et al. 1981. The formation of a structure with the features of a synovial lining by subcutaneous injection of air: an in vivo tissue culture system. J. Pathol. 134: 147-156.